| First Author | O'Neill LM | Year | 2020 |
| Journal | Int J Mol Sci | Volume | 21 |
| Issue | 22 | PubMed ID | 33207603 |
| Mgi Jnum | J:303497 | Mgi Id | MGI:6514469 |
| Doi | 10.3390/ijms21228619 | Citation | O'Neill LM, et al. (2020) Stearoyl-CoA Desaturase-2 in Murine Development, Metabolism, and Disease. Int J Mol Sci 21(22):8619 |
| abstractText | Stearoyl-CoA Desaturase-2 (SCD2) is a member of the Stearoyl-CoA Desaturase (SCD) family of enzymes that catalyze the rate-limiting step in monounsaturated fatty acid (MUFA) synthesis. The MUFAs palmitoleoyl-CoA (16:1n7) and oleoyl-CoA (18:1n9) are the major products of SCD2. Palmitoleoyl-CoA and oleoyl-CoA have various roles, from being a source of energy to signaling molecules. Under normal feeding conditions, SCD2 is ubiquitously expressed and is the predominant SCD isoform in the brain. However, obesogenic diets highly induce SCD2 in adipose tissue, lung, and kidney. Here we provide a comprehensive review of SCD2 in mouse development, metabolism, and various diseases, such as obesity, chronic kidney disease, Alzheimer's disease, multiple sclerosis, and Parkinson's disease. In addition, we show that bone mineral density is decreased in SCD2KO mice under high-fat feeding conditions and that SCD2 is not required for preadipocyte differentiation or the expression of PPARgamma in vivo despite being required in vitro. |
